baber/WOPTO huggingface dataset:
Patent JP-2001519918-A (JP)
IPC: G09F3/00
Filed: 1998-03-03
Abstract: A radio frequency identification device includes an attachment element (12) which is maintained in operative relationship with an object or individual by a securement element (14). The attachment element (14) is disposable and the securement element (14) is easily separable therefrom for reuse, the securement element (14) including a radio frequency identification circuit (30) which can be reused after the attachment element (12) has been disposed of. One form of the radio frequency identification device is an identification wristband (10) which incorporates attachment element (12) and securement element (14) for the attachment element (12), the securement element (14) incorporating an RFID such as a chip (30) which is removed from operative relationship with the attachment element (12) when the securement element (14) is removed to permit reuse of the securement element (14) and chip (30).
Patent JP-2001516378-A (JP)
Title: 加硫弗素化エラストマのリサイクル
IPC: C08K5/435
Filed: 1998-03-09
Abstract: (57)【要約】
架橋された（すなわち、加硫または硬化された）フルオロエラストマを効果的にリサイクルするのに有効な組成物および技法が開示されている。本発明は、硬化増強剤、架橋剤、および促進剤を含む添加剤系を利用する。
Patent JP-H11509460-A (JP)
IPC: A61F2/00
Filed: 1997-05-14
Abstract: The cotyloidal implant has a hemispherical cup (5) forming an internal cavity (10), and an insert (7) engageable into the cavity, the cup being set in place by impaction and having to this effect anchoring asperities (15) provided on its external face, having the form of lozenges and which are contiguous and imbricated. The cup (5) is provided, on its external face, with two coaxial grooves configured like helical threads (38) having reverse pitches which intersect each other on a large portion of said external face, which are inclined in the direction of the cup opening and which have a depth increasing progressively in the opening direction of the cup (5); due to their intersection, the grooves delimit an important number of asperities (15). The invention provides for the making of a cotyloidal implant which can be anchored to the pelvis without the use of cement and screws.
Patent JP-2001522579-A (JP)
Title: 特に車両のスライド式屋根を調節するための駆動装置
IPC: H02K11/026
Filed: 1998-12-11
Abstract: (57)【要約】
公知の駆動装置は、プリント配線板上に配置されたブラシ保持具を有しており、組付け時には可動子を整流子と一緒に相応に通し入れるか、もしくは調整しなければならない。これに対して本発明により、プリント配線板（３０）上に構成部材として装備されたブラシ保持具（２６）が提案される。ブラシ保持具（２６）は駆動装置（１）の伝動装置ケーシング（１０）内に設けられた凹部（２３）内に挿入され、その際にすでに最終的に組み付けられた可動子（１４）の整流子（１８）に半径方向に被せ嵌め可能である。本発明による駆動装置は、特に車両のスライド式屋根を調節するために設けられている。
Patent JP-2001517995-A (JP)
Title: 冠状静脈洞を介する心臓調歩または細動除去用心臓内リード線
IPC: A61F2/962
Filed: 1998-03-24
Abstract: (57)【要約】
冠状静脈洞内への配置に特に有用な心臓内リード線集成体（１０）が開示される。リード線集成体は開放端または密閉端をもつことができる。密閉端をもつリード線集成体は、通常の埋込手順を用いて埋め込むことができる。開放端をもつリード線集成体は、初めにスタイレットを患者の身体内に置き、次いでスタイレットに沿ってリード線を患者の身体に挿入することにより埋め込むことができる。開示されるリード線集成体のそれぞれは、リード線が適切な位置に置かれると展開して血管の内表面に接触するステント（４０ａ，４０ｂ）を１つ以上用いる。すなわち、ステントは所望の位置にリード線を固定する。さらに、ステントは調歩及び／または検知用電極として用いることができる。
Patent JP-2001503067-A (JP)
Title: チゾキサニドおよびニタゾキサニドの薬剤の合成物
IPC: A61P33/12
Filed: 1998-05-06
Abstract: (57)【要約】
化学式（Ｉ）の化合物
 および化学式（II）の化合物
 からなるグループから少なくとも１つ選択された化合物を活性剤として含有する薬剤の合成物。前記活性剤は好ましくは２００μｍより小さい粒子サイズで、１０μｍより大きい平均粒子サイズを有する粒子からなる。前記薬剤の合成物は好ましくは少なくとも１つの薬剤的に許容可能な酸に固定される。前記薬剤の合成物は特に免疫不全あるいは抑制された免疫系を有する人の日和見感染治療に、あるいは吸虫感染症の治療に役立つ。
Patent JP-2002509632-A (JP)
Title: 文書、特に技術図面を分割し認識する方法
IPC: G06T7/00
Filed: 1999-05-06
Abstract: (57)【要約】
本発明の目的は、映像の中に含まれ、以下のものを持つ情報を処理する方法である：−  映像（８）の対象領域を定義する第１の処理段階（１−４）と、−  第１の閾値映像として参照される、対象領域の閾値映像（１０）を得るために、適応閾値を定める（１−８）段階と、−  閾値映像の形態層（１４−１，１４−２，１４−３，．．．）の第１の組を得るために、閾値映像を分割（１−１２）する段階。
Patent NZ-199224-A (NZ)
Title: Manufacture of a cds photovoltaic device
Inventor: LAURIE A S
IPC: H01L31/18
Filed: 1981-12-10
Abstract: The invention relates to the manufacture of a cadmium sulphide photo-voltaic device. A substrate such as a glass is coated with successive layers which are made, in order, of tin oxide, cadmium sulphide, cuprous sulphide and copper to build up a photo-voltaic junction. In order to achieve a fast deposition rate of the cadmium sulphide while achieving a well ordered crystal structure the cadmium sulphide layer is deposited in two stages, the first involving spraying of a weak precursor solution and the second a substantially more concentrated solution to achieve at least a five times increase in the deposition rate. The invention also describes improved techniques for spraying and reducing the effects of the resistivity of the tin oxide first electrode.
Patent NZ-200680-A (NZ)
Title: Cytoprotection by administration of prostaglandins
Inventor: SHRIVER D A
IPC: A61K31/557
Filed: 1982-05-19
Abstract: A pharmaceutical composition for use in inducing cytoprotection in mammals comprises the prostaglandin derivative 16-methyl-1,11 alpha , 16RS- trihydroxyprost-13E-en-9-one in a pharmaceutically acceptable carrier.
Patent NZ-201698-A (NZ)
Title: Composition of antibodies specific to endotoxins
Inventor: GAFFIN S L
IPC: A61K39/40
Filed: 1982-08-24
Abstract: The invention is concerned with the problem of gram-negative bacteremia and endotoxemia. The invention provides a composition comprising one or more antibodies which are specific to one or more endotoxins, especially those produced by gram-negative bacteria, in admixture with a carrier medium. The carrier medium may be animal or human serum, milk or a synthetic material. The invention also provides a method of producing a composition comprising an antibody or a mixture of antibodies specific to endotoxin(s), including the steps of inoculating a suitable animal with an antigen or mixture of antigens capable of triggering the appropriate immunological response in the animal, and removing a body fluid comprising the resulting antibody or mixture of antibodies.
Patent NZ-206668-A (NZ)
Title: Filter press electrolyser
Inventor: ABRAHAMSON D W
IPC: C25B9/19
Filed: 1983-12-21
Abstract: Monopolar, bipolar, and highbrid filter press electrolytic cells for electrolytic processes utilizing a novel method of introducing and removing electrical energy. The invention contemplates a novel low pressure, high surface contact area connecting means for joining the anode element and cathod element of electrode assemblies. The invention also contemplates a low pressure, high surface contact area contact of the current distributor member to the back plate.
Patent NZ-207470-A (NZ)
Title: Absorption type heat pump:evaporator,condenser,absorber and vapour generator in form of rotating discs
Inventor: CROSS W T
IPC: F25B15/02
Filed: 1984-03-12
Abstract: An absorption heat pump is described comprising at least an evaporator, an absorber, a vapour generator and a condenser and in which at least one of the components is in the form of one or more rotatable plates across the thickness of which plate(s) a heat transfer takes place. Such a heat pump can be designed in compact form.
Patent NZ-213117-A (NZ)
Title: Composition and method for increasing ruminant feed utilisation efficiency; process for preparing a microbial culture for such a composition
Inventor: OTT I
IPC: A23K1/18
Filed: 1985-08-15
Abstract: The invention relates to a composition for improving the efficiency of ruminant feed utilization, which comprises one or more microbial cultures, which are capable of adjusting the weight ratio of acetic acid to propionic acid produced during fermentation of energy-producing nutrients in the rumen of an animal to an optimum value, preferably to 1.5-4.0:1, and of growing in the rumen and persisting there at least for 60 days. The cultures may optionally be in admixture with carriers, diluents, and preserving agents conventionally used in animal husbandry and nutritive and/or other substances conventionally administered to ruminants. According to another aspect of the invention there is provided a process for the preparation of microbial cultures used as active ingredient in the above composition. The invention further relates to a process for the preparation and use of said compositions.
Patent NZ-235636-A (NZ)
Title: Using dsrna for the treatment of shock subsequent to injury
Inventor: EINCK LEO
IPC: A61P31/04
Filed: 1990-10-11
Abstract: The present invention details the use of double-stranded RNA (dsRNA) for reactivation of natural defense systems within human cells, tissues and organs reduced to inadequate function subsequent to injury. Specific treatments for acquired immune deficient states are described. dsRNA stimulates the release of an immune lymphokine, tumor necrosis factor (TNF) and protects against the toxic effects associated with increased TNF levels.
Patent NZ-242065-A (NZ)
Title: Delayed release implant having a degradable or rupturable polymeric coating
Inventor: BARR IAN GEORGE
IPC: A61K9/22
Filed: 1992-03-19
Abstract: PCT No. PCT/AU92/00124 Sec. 371 Date Nov. 17, 1993 Sec. 102(e) Date Nov. 17, 1993 PCT Filed Mar. 25, 1992 PCT Pub. No. WO92/17165 PCT Pub. Date Oct. 15, 1992The invention provides a pharmaceutical or veterinary implant, which when parenterally administered releases a pulse of at least one biologically active material at a controllable time interval after implantation. The implant comprises the biologically active material; an excipient comprising at least one water soluble material and at least one water insoluble material; and a polymer film coating adapted to rupture at a predetermined period of time after implantation, and wherein the excipients and polymers are biocompatible. The biologically active material is selected from the group consisting of antigens, antibodies, hormones, growth promotants, antibiotics, nutrients, minerals and vitamins. Preferably the excipient comprises a combination of two or more water-soluble and water-insoluble materials.
Patent NZ-243485-A (NZ)
Title: Copolymer solutions based on the reaction product of unsaturated carboxylic acids, glycidyl esters, other unsaturated monomers and polysiloxanes; two component coating compositions
Inventor: DOS SANTOS ANTONIO MANUEL
IPC: C09D125/14
Filed: 1992-07-09
Abstract: The invention relates to copolymer solutions of copolymers of the abovementioned type, which, after the copolymerisation, has an unusually high solids content (about 80 % by weight) and can be converted, with polyisocyanates into two-component coatings having a high solids content and good processing viscosity. Copolymers contain a cocondensed methoxy-functional polysiloxane. The copolymers can be converted with amino resins into binders for stoving coatings (baking coatings or paints) which, as improved varnishes for automotive finishes, give paint films which have excellent abrasion resistance in automatic car washes.
Patent NZ-246820-A (NZ)
Title: Floodlighting using sequentially arranged reflectors
Inventor: GORDIN MYRON K
IPC: E01F9/615
Filed: 1993-01-13
Abstract: A highly controllable way to light target areas includes a primary reflector (34) which generates a defined primary beam (40) in association with a light source (30). The primary beam (40), or at least a portion of the primary beam, is directed onto a secondary reflector (42) which generates a secondary beam (44) to the target space. The secondary reflector (42) can be configured in any number of contours, shapes, specularities, or other characteristics to alter and control the characteristics of the secondary beam (44). Various options, alternatives, and features are possible with the invention. For example, a plurality of light sources (30) and primary reflectors (34) can be used with one secondary reflector (42). The surface of the secondary reflector (42) can be corrugated to have alternating segments to direct light in different directions. A combination of light source (30), primary reflector (34), and secondary reflector (42) can also be positioned on a moveable base. A plurality of secondary reflectors (42) and light sources (30) and primary reflectors (34) can be positioned on one moveable base and can be oriented in different configurations for different lighting effects. The invention can be used to light a variety of areas, including highways, spectator events and locations where significant control of light is needed. <IMAGE>
Patent NZ-249302-A (NZ)
Title: 4,5-diphenyl-1,3,2-oxazaborolidine derivatives and their use as catalysts in reduction of ketones to chiral alcohols
Inventor: QUALLICH GEORGE J
IPC: C07B41/02
Filed: 1993-02-01
Abstract: The borane reduction of prochiral ketones to optically pure alcohols is effectively achieved by the utilization of catalytic amounts of the new and valuable oxazaborolidine catalysts of formula (I).
Patent NZ-250047-A (NZ)
Title: Multilayer pasteurisable and/or cook-in shrink film having an inner sealable layer of ethylene-butylacrylate-maleic anhydride copolymer
Inventor: FORLONI ROBERTO
IPC: B65D65/40
Filed: 1993-10-26
Abstract: A pasteurizable and/or cook-in multilayer shrink film, which is characterized in that the innermost sealing layer comprises an ethylene-butyl acrylate-maleic anhydride copolymer.
Patent NZ-259576-A (NZ)
Title: Estimating presence of microorganisms by estimating adenylate kinase levels by its ability to convert adp to atp
Inventor: SQUIRRELL DAVID JAMES
IPC: C12Q1/04
Filed: 1994-01-21
Abstract: A method for determining the presence and/or amount of microorganisms and/or their intracellular material present in a sample comrpising estimating the amount of adenylate kinase therein by its ability to convert adenosine diphosphate (ADP) to adenosine triphosphate (ATP) and relating that to the presence/or amount of organism and/or intracellular material. The method provides improved sensitivity over existing luciferase/luciferin assays. Reagents including purified ADP and adenyl kinase free luciferase are provided together with test kits including these and apparatus for automated operation of the method.
Patent NZ-262582-A (NZ)
Title: Compositions and methods for delivery of genetic material
Inventor: WEINER DAVID B
IPC: C12N15/87
Filed: 1994-01-26
Abstract: Methods of introducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a polynucleotide function enhancer and administering to the cells, a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produces a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV am disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.
Patent NZ-270749-A (NZ)
Title: Pharmaceutical use of deoxyspergualin
Inventor: LINDNER JURGEN
IPC: A61K31/16
Filed: 1995-03-20
Abstract: Use of deoxyspergualin (I), i.e. ( plus or minus )-1-amino-19-guanidino-11-hydroxy-4,9,12-triaza-nonadecane-10,13-dione .3HCl, to prepare a medicament for therapy and prophylaxis of inflammatory hyperreactive diseases is new.
Patent NZ-309512-A (NZ)
Title: Compositions and methods to prevent microbial contamination of plant tissue culture media
Inventor: GURI ASSAF Z
IPC: C12N5/02
Filed: 1996-06-03
Abstract: The present invention encompasses compositions and methods to reduce or prevent microbial growth in plant tissue culture media, comprising adding a chemical agent comprising methylchloroisothiazolinone, methylisothiazolinone, magnesium chloride and magnesium nitrate to a plant culture medium at a concentration that reduces or prevents microbial contamination of the plant tissue culture medium and that allows substantially normal germination of seeds or substantially normal growth or development of plants, plant organs, plant tissues or plant cells. The chemical agent may further comprise potassium sorbate or sodium benzoate, or both. The present invention further provides a kit for germinating plant seeds or culturing plants, plant organs, plant tissues or plant cells on a plant tissue culture medium comprising the chemical agent.
Patent NZ-314728-A (NZ)
Title: Liquid level indicating device comprising a float attached to a cable which in turn is attached to a rotatable mounting means
Inventor: CARPENTER CARL WILLIAM
IPC: G01F23/42
Filed: 1998-07-02
Abstract: A fluid level indicator for tanks includes a thread 1 running over a pulley 3 with a float 2 for floating in the fluid in the tank attached to one end of the thread and a counterweight 3 attached to the other end of the thread.  The sprocket 9 driven coaxially with the pulley engages the teeth on the periphery of the indicator wheel 7.  As the level of the float changes with change of fluid level in the tank, the thread rotates the pulley 3 and thereby the indicator wheel 7.
Patent NZ-324796-A (NZ)
Title: Remote control of electrical apparatus via telephone network, central controller periodically polls remote locations to determine status of electrical apparatus
Inventor: NOLDE KEITH ERIC
IPC: H04M11/00
Filed: 1996-12-31
Abstract: A remote control system for controlling electrical apparatus in a customers premises includes a home control interface 15 which is connected to a communications network such as the public telephone system.  The control interface receives signals from a central home control platform through the communications network.  The signals are used to switch on and off electrical apparatus by way of module interfaces 16.  A customer forwards remote control requests by telephone to the central control platform, which then forwards the requests to the home control interface.  This interface transmits information about the on/off status of the electrical apparatus back to the central control platform when periodically polled by the central control platform.  This status data is stored by the central control platform, and can be used to inform the customer, or to cause an update the on/off status of the electrical apparatus if required by the customer.
Patent NZ-333043-A (NZ)
Title: Multiple power generator system with cryogenically cooled converter
Inventor: GOLD CALMAN
IPC: H02M5/458
Filed: 1995-08-03
Abstract: A power generation system includes power generators such as variable speed turbines that each generate current input signals having a naturally occurring fluctuating frequency characteristic, and power conversion circuitry 12 for generating output signals in response to the current input signals.  The power conversion circuitry is provided with a cryogenic cooling system.
Patent NZ-333340-A (NZ)
Title: Electric fence netting
Inventor: WEINREICH WILHELM
IPC: A01K3/00
Filed: 1998-12-14
Abstract: This application discloses electric mesh fencing for fields.  The fencing comprises interlinked vertical and horizontal wire strands with only some of the horizontal strands formed as electrical conductors (3) with high conductivity whilst the other horizontal strands are non-conducting. Vertical conductor strands (4) with a clearly lower conductivity are attached to the horizontal conductor strands at predetermined intervals. Preferably the horizontal strand furthest from the ground forms the conductor strand with high conductivity and the vertical conductor strands extend over the fence height keeping sufficient space from the ground to maintain insulation
Patent NZ-334941-A (NZ)
Title: Methods for treating infections using proteins which induce an immune response in one animal species but not in another
Inventor: GELDER FRANK B
IPC: A61K39/00
Filed: 1997-10-10
Abstract: This method for treatment, diagnosis and prevention of a pathogen infection comprises administering to a patient antibodies which react with regions of proteins which fail to elicit an immune response in man when encountered through infection or naturally through the environment, but do elicit an immune response in non-human animals.  The immunological non-responsiveness in man is thought to be a function of molecular mimicry and lack of MHC associated events.  HIV proteins with the characteristics described above are selected as follows.   HIV proteins are isolated from a lysate of an HIV strain, treated to remove HLA class I and class II antigens, and used to immunize a non-human mammal.  The antisera from this mammal is employed in a competitive immunoassay with human HIV antisera to identify regions of HIV proteins which are recognized by antibodies in the mammal antisera, but not recognized by antibodies in the human antisera.  Antibodies to the epitope from the immunized host may be administered to a patient to treat or prevent infection.  Particular HIV1sF2 proteins investigated are:  (a) envelope gp120 external glycoprotein; (b) envelope gp41 transmembrane glycoprotein; (c) reverse transcriptase; (d) protease p1O; or (e) gag precursor
Patent NZ-336934-A (NZ)
Title: A coating material for radiation surfaces to produce electromagnetic waves composed of a binding agent, insulating agent, dispersing agent, water and graphite
Inventor: REICHELT HELMUT
IPC: C09D5/00
Filed: 1998-04-21
Abstract: A coating material for radiation surfaces to produce electromagnetic waves and a method for manufacturing the material. The coating material is a mixture consisting of a binding agent, an insulating agent, a dispersing agent, water and graphite.  A polyvinyl acetate and/or a polyacrylate and/or a polypeptide is used as the binding agent, while an insulating soot is used as an insulating agent.  The graphite, soot and binding agent form electric dipoles in the coating material which emit electromagnetic waves in the excited state. The coating material has the following composition: a. 55 to 65% amount of substance (mole fraction) of a base material comprising - 39 to 49% amount of substance binding agent, - 18 to 23% amount of substance insulating agent, - 18 to 24% amount of substance dispersing agent, - 12 to 16% amount of substance distilled water, and b. 35 to 45% amount of substance graphite, the composition of the binding agent being - 64 to 79% amount of substance distilled water, - 4 to 6% amount of substance sulphated oil, - 0.16 to 0.24% amount of substance phenols or 0.05 to 0.5% amount of substance benzoisothiazolinon, - 15 to 19% amount of substance casein, - 0.8 to 1.2% amount of substance urea, - 2 to 3% amount of substance alkali diluent, and - 2.5 to 3.5% amount of substance caprolactam.
Patent NZ-501803-A (NZ)
Title: Generation of packaging system for human recombinant adenoviral vectors
Inventor: VOGELS RONALD
IPC: C12N7/01
Filed: 1999-04-23
Abstract: A method for generating an adenovirus vector comprising welding together two nucleic acid molecules whereby said molecules comprise partially overlapping sequences capable of combining with each other allowing the generation of a physically linked nucleic acid comprising at least two functional adenovirus inverted terminal repeats, a functional encapsulation signal and a nucleic acid of interest or functional parts, derivatives and/or analogues thereof.  The two nucleic acids are replicated, prior to welding together, using a nucleic acid replication system independent of adenovirus.  Also disclosed are nucleic acid molecules for generation adenovirus vectors.
Patent NZ-505999-A (NZ)
Title: Passive telecommunication monitor system
Inventor: GALBRAITH BRUCE GRAHAM
IPC: H04M3/30
Filed: 1998-12-28
Abstract: A passive system for monitoring a voice, data, image, text or other telecommunications media by a customer, which connects the line (12) to be monitored to a processing unit (14) which measures the signals passing through the line (12) and compares these measured signals with predetermined values or monitors the progress of the call. The measurement means determines the static state of the line to see if the line is satisfactory and also determines the dynamic state of the lines by monitoring the progress of the call on the lines.  Also, including a visual display (16) or audible alarm (16) for indicating the status of the line as determined by the comparator (14) or the call progress monitor (14).